Asked by: Rachael Maskell (Labour (Co-op) - York Central)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps her Department is taking to ensure that intensive care units have a full complement of rehabilitation staff.
Answered by Helen Whately - Minister of State (Department of Health and Social Care)
Local trusts are responsible for planning their service capacity to meet expected demand.
The NHS Long Term Workforce Plan (LTWP) sets out the steps the National Health Service and its partners need to take to deliver an NHS workforce that meets the changing needs of the population over the next 15 years. Backed by over £2.4 billion, the LTWP will significantly expand education and training places, including of allied health professionals.
Asked by: Taiwo Owatemi (Labour - Coventry North West)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if she will make an estimate of the number of pharmacies that have closed in Coventry North West constituency since 2019; and if she will make an assessment of the potential impact of pharmacy closures on primary care standards.
Answered by Andrea Leadsom - Parliamentary Under-Secretary (Department of Health and Social Care)
On 31 December 2023, there were 22 pharmacies in Coventry North West constituency, including one distance selling pharmacy. Between 31 December 2019 and 31 December 2023, two pharmacies closed in Coventry North West and no new pharmacies opened. However, access to pharmaceutical services remains good, with 97% of the population of Coventry North West living within a 20-minute walk from a pharmacy. This exceeds the national average of 80%. Residents of Coventry North West can also access services from distance selling pharmacies that operate nationally.
It is the role of local authorities in England to undertake pharmaceutical needs assessments for their areas, every three years, to ensure provision continues to meet their population’s needs. Integrated care boards (ICBs) have regard to those assessments when commissioning services and where a pharmacy closure impacts on the access to services, a new contractor can apply to open a pharmacy in the area.
Services within the National Health Service delivered in community pharmacy can have a positive impact on secondary care. For example, the Discharge Medicines Service and the New Medicine Service provide patients with extra support for medicines preventing (re)hospitalisation. Urgent and emergency care settings can also refer patients to community pharmacies for a minor illness consultation or an urgent medicine supply, taking the pressure off secondary care. Increasing the impact of these services, which are already commissioned in community pharmacies, will require continued embedding of referral in secondary care pathways.
Asked by: Taiwo Owatemi (Labour - Coventry North West)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment her Department has made of the potential impact of increasing funding for community pharmacies on funding for secondary care.
Answered by Andrea Leadsom - Parliamentary Under-Secretary (Department of Health and Social Care)
On 31 December 2023, there were 22 pharmacies in Coventry North West constituency, including one distance selling pharmacy. Between 31 December 2019 and 31 December 2023, two pharmacies closed in Coventry North West and no new pharmacies opened. However, access to pharmaceutical services remains good, with 97% of the population of Coventry North West living within a 20-minute walk from a pharmacy. This exceeds the national average of 80%. Residents of Coventry North West can also access services from distance selling pharmacies that operate nationally.
It is the role of local authorities in England to undertake pharmaceutical needs assessments for their areas, every three years, to ensure provision continues to meet their population’s needs. Integrated care boards (ICBs) have regard to those assessments when commissioning services and where a pharmacy closure impacts on the access to services, a new contractor can apply to open a pharmacy in the area.
Services within the National Health Service delivered in community pharmacy can have a positive impact on secondary care. For example, the Discharge Medicines Service and the New Medicine Service provide patients with extra support for medicines preventing (re)hospitalisation. Urgent and emergency care settings can also refer patients to community pharmacies for a minor illness consultation or an urgent medicine supply, taking the pressure off secondary care. Increasing the impact of these services, which are already commissioned in community pharmacies, will require continued embedding of referral in secondary care pathways.
Asked by: Jim Shannon (Democratic Unionist Party - Strangford)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps her Department is taking to help reduce waiting times for an ADHD diagnosis on the NHS for children.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
It is the responsibility of integrated care boards (ICBs) to make available appropriate provision to meet the health and care needs of their local population, including access to attention deficit hyperactivity disorder (ADHD) assessments, in line with relevant National Institute for Health and Care Excellence (NICE) guidelines. NICE guidelines for ADHD diagnosis and management aim to improve the diagnosis of ADHD, and the quality of care and support people receive. The NICE guidelines do not recommend a maximum waiting time standard for ADHD diagnosis, either from referral for an assessment to receiving an assessment, a diagnosis, or a first contact appointment.
We know that children and young people often seek an ADHD diagnosis through Child and Adolescent Mental Health Services. Through the NHS Long Term plan, the Government is investing record amounts into children and young people’s mental health services.
There is, at present, no single, established dataset that can be used to monitor waiting times for assessment or treatment for ADHD nationally. The Department is exploring options to improve data collection and reporting on ADHD assessment waiting times, to help improve access to ADHD assessments in a timely way, and in line with the NICE guideline. In support of this, the National Institute for Health and Care Research Policy Research Programme has commissioned a research project to provide insights into local ADHD diagnosis waiting time data collection.
NHS England is establishing a new ADHD taskforce alongside the Government, to improve care for people living with the condition. The new taskforce will bring together expertise from across a broad range of sectors, including the National Health Service, education, and justice, to better understand the challenges affecting people with ADHD, and help provide a joined-up approach in response to concerns around rising demand for assessments and support.
Alongside the work of the taskforce, NHS England has announced that it will continue to work with stakeholders to develop a national ADHD data improvement plan, carry out more detailed work to understand the provider and commissioning landscape, and capture examples from local health systems who are trialling innovative ways of delivering ADHD services to ensure best practice is captured and shared across the system.
Asked by: Rachael Maskell (Labour (Co-op) - York Central)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if she will take steps to ensure that best practice in palliative and end of life care is shared across the NHS.
Answered by Helen Whately - Minister of State (Department of Health and Social Care)
The Government recognises that access to high-quality palliative and end of life care can make all the difference to individuals and their loved ones. NHS England meets regularly with regional and system leaders, providing a forum for the sharing of best practice. In addition, there is a palliative and end of life care workspace available on the FutureNHS Collaborative Platform, which includes a range of resources, case studies, and discussion fora, with access to the platform available for anyone with a NHS.net email account.
NHS England has developed a palliative and end of life care dashboard, which brings together all relevant local data in one place. The dashboard helps commissioners understand the palliative and end of life care needs of their local population, enabling integrated care boards (ICBs) to put plans in place to address and track the improvement of health inequalities, and ensure that funding is distributed fairly, based on prevalence.
As of April 2024, NHS England is including palliative and end of life care in the list of topics for regular performance discussions between national and regional leads. These meetings will provide an additional mechanism for supporting ICBs to continue improving palliative and end of life care for their local population.
The Ambitions Framework, refreshed by the National Palliative and End of Life Care Partnership, which is made up of NHS England and 34 partner organisations with experience of, and responsibility for, end of life care, sets out the vision to improve end of life care through partnership and collaborative action between organisations at local level throughout England, by setting out six key ambitions.
Furthermore, the National Institute for Health and Care Excellence (NICE) has published guidance and quality standards on end of life care for adults, and children and young people. These are based on best practice in developing and delivering care and, while not statutory, there is an expectation that commissioners and service providers take the guidelines into account when making decisions about how to best meet the needs of their local communities.
Asked by: Angela Eagle (Labour - Wallasey)
Question to the Department for Work and Pensions:
To ask the Secretary of State for Work and Pensions, if he will make a comparative estimate of the number of people who were economically inactive and waiting for NHS treatment by (a) nation and (b) region as of (i) 23 April 2010 and (ii) 23 April 2024.
Answered by Mims Davies - Minister of State (Department for Work and Pensions)
The information available on the number of people who were economically inactive and waiting for NHS treatment is given below.
The Office for National Statistics (ONS) has published waiting times for a hospital appointment, test or to start receiving treatment through the NHS for those who are economically inactive as part of the Opinions and Lifestyles Survey. This data is available for Great Britain and is not available at lower-level geographies and the earliest available data is for 22 November to 18 December 2022 therefore a comparison with 2010 at a national and regional level cannot be made.
The latest Opinions and Lifestyle Survey data shows that the number of economically inactive adults aged 16 years and over in Great Britain is 6.9 million, excluding those who are retired (18 October 2023 to 1 January 2024). Economically inactive adults will, for example, include adults who are studying, have caring responsibilities or are long-term sick. Of this population, between 2.1 million (30%) and 2.6 million (38%) are currently waiting for a hospital appointment, test, or to start receiving medical treatment through the NHS.
Asked by: Lord Mendelsohn (Labour - Life peer)
Question to the Department for Environment, Food and Rural Affairs:
To ask His Majesty's Government what assessment they have made of the impact of animal population decline in other countries on the UK, following the WWF’s Living Planet Report 2022 which showed that worldwide animal populations have declined by 69 per cent since 1970.
Answered by Lord Benyon - Minister of State (Foreign, Commonwealth and Development Office)
The UK is susceptible to impacts from animal population decline worldwide through global impacts on food supply and the increasing emergence and transmission of diseases. For example, the Intergovernmental Science-Policy Platform on Biodiversity and Ecosystem Services (IPBES) Pollinators Assessment showed that 35% of global crop production volume depends on animal pollination, while the IPBES Workshop report on Biodiversity and Pandemics showed that over 30% of emerging disease events are caused by land-use change and its impacts on wildlife. Healthy ecosystems are also vital for mitigating and adapting to climate change, thus animal population declines may also exacerbate the climate impacts felt by the UK, as set out in the UK’s Climate Change Risk Assessment. The UK Government with others continues to support the work of the IPBES and the Intergovernmental Panel on Climate Change to further understand these global impacts.
A recently published report from the Green Finance Institute, entitled ‘Assessing the Materiality of Nature-Related Financial Risks for the UK’, with direction from Defra and others, showed that about half of all UK nature-related risk comes from overseas, through supply chains and financial exposures. It showed that the combination of biodiversity loss and environmental degradation could lead to major economic shocks leading to UK Gross Domestic Product being up to 12% lower that it may otherwise have been by the 2030s (even lower when combined with climate impacts).
Asked by: Seema Malhotra (Labour (Co-op) - Feltham and Heston)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, with reference to section 1.17 of the National Institute for Health and Care Excellence (NICE) guidelines entitled Myalgic encephalomyelitis (or encephalopathy) chronic fatigue syndrome: diagnosis and management, published on 29 October 2021, what steps her Department is taking to help ensure that hospital staff are aware of NICE guidelines for caring patients with very severe myalgic encephalomyelitis.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
The National Institute for Health and Care Excellence’s (NICE) guideline, Myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome: diagnosis and management, published in October 2021, outlines the expectations for inpatient care for patients with myalgic encephalomyelitis (ME), also known as chronic fatigue syndrome. The guidance states that where possible, patients with ME should be provided with a single room, and that factors such as the level of lighting and sound should be taken into consideration, and necessary adjustments made.
It is the duty of clinicians to keep themselves appraised of best practice, in particular guidance issued by the NICE. Whilst guidelines are not mandatory, clinicians and commissioners are expected to take them fully into account when designing services that meet the needs of their local population. The NICE promotes its guidance via its website, newsletters, and other media.
The Department is working with NHS England to develop an e-learning course on ME for healthcare professionals, with the aim of supporting staff in providing better care and improving patient outcomes. The Medical Schools Council will promote the NHS England e-learning package on ME to all United Kingdom medical schools, and encourage medical schools to provide undergraduates with direct patient experience of ME.
We have finished consulting on My Full Reality, the cross-Government interim delivery plan on ME, which seeks to improve the experiences and outcomes of people living with this condition. We are in the process of analysing the results of the consultation. The views and experiences gathered through this consultation will be used to build a picture of how well the interim delivery plan identifies and meets the needs of the ME community, and to highlight any significant gaps where further action may be necessary. We will publish a summary of the consultation responses, which will inform the final delivery plan being published later this year, in due course.
Asked by: Seema Malhotra (Labour (Co-op) - Feltham and Heston)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 11 March 2024 to Question 16630 on Chronic Fatigue Syndrome, when she plans to publish the final myalgic encephalomyelitis delivery plan.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
The National Institute for Health and Care Excellence’s (NICE) guideline, Myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome: diagnosis and management, published in October 2021, outlines the expectations for inpatient care for patients with myalgic encephalomyelitis (ME), also known as chronic fatigue syndrome. The guidance states that where possible, patients with ME should be provided with a single room, and that factors such as the level of lighting and sound should be taken into consideration, and necessary adjustments made.
It is the duty of clinicians to keep themselves appraised of best practice, in particular guidance issued by the NICE. Whilst guidelines are not mandatory, clinicians and commissioners are expected to take them fully into account when designing services that meet the needs of their local population. The NICE promotes its guidance via its website, newsletters, and other media.
The Department is working with NHS England to develop an e-learning course on ME for healthcare professionals, with the aim of supporting staff in providing better care and improving patient outcomes. The Medical Schools Council will promote the NHS England e-learning package on ME to all United Kingdom medical schools, and encourage medical schools to provide undergraduates with direct patient experience of ME.
We have finished consulting on My Full Reality, the cross-Government interim delivery plan on ME, which seeks to improve the experiences and outcomes of people living with this condition. We are in the process of analysing the results of the consultation. The views and experiences gathered through this consultation will be used to build a picture of how well the interim delivery plan identifies and meets the needs of the ME community, and to highlight any significant gaps where further action may be necessary. We will publish a summary of the consultation responses, which will inform the final delivery plan being published later this year, in due course.
Asked by: Seema Malhotra (Labour (Co-op) - Feltham and Heston)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether her Department is taking steps to increase inpatient provision for patients with myalgic encephalomyelitis.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
The National Institute for Health and Care Excellence’s (NICE) guideline, Myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome: diagnosis and management, published in October 2021, outlines the expectations for inpatient care for patients with myalgic encephalomyelitis (ME), also known as chronic fatigue syndrome. The guidance states that where possible, patients with ME should be provided with a single room, and that factors such as the level of lighting and sound should be taken into consideration, and necessary adjustments made.
It is the duty of clinicians to keep themselves appraised of best practice, in particular guidance issued by the NICE. Whilst guidelines are not mandatory, clinicians and commissioners are expected to take them fully into account when designing services that meet the needs of their local population. The NICE promotes its guidance via its website, newsletters, and other media.
The Department is working with NHS England to develop an e-learning course on ME for healthcare professionals, with the aim of supporting staff in providing better care and improving patient outcomes. The Medical Schools Council will promote the NHS England e-learning package on ME to all United Kingdom medical schools, and encourage medical schools to provide undergraduates with direct patient experience of ME.
We have finished consulting on My Full Reality, the cross-Government interim delivery plan on ME, which seeks to improve the experiences and outcomes of people living with this condition. We are in the process of analysing the results of the consultation. The views and experiences gathered through this consultation will be used to build a picture of how well the interim delivery plan identifies and meets the needs of the ME community, and to highlight any significant gaps where further action may be necessary. We will publish a summary of the consultation responses, which will inform the final delivery plan being published later this year, in due course.